ZIOPHARM commences early-stage study of gene therapy Ad-RTS-hIL-12 in pediatric brain tumors – Seeking Alpha
ZIOPHARM commences early-stage study of gene therapy Ad-RTS-hIL-12 in pediatric brain tumorsSeeking AlphaAd-RTS-hIL-12 is a novel gene therapy candidate for the controlled expression of interleukin-12 (IL-12), an essential protein for stimulating a T c… Continue reading
